Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies

Purpose of review For three decades, portal vein embolization (PVE) has been the “gold-standard” strategy to hypertrophy the anticipated future liver remnant (FLR) in advance of major hepatectomy. During this time, CT volumetry was the most common method to preoperatively assess FLR quality and function and used to determine which patients are appropriate surgical candidates. This review provides the most up-to-date methods for preoperatively assessing the anticipated FLR and summarizes data from the currently available strategies used to induce FLR hypertrophy before surgery for hepatobiliary malignancy. Recent findings Functional and physiological imaging is increasingly replacing standard CT volumetry as the method of choice for preoperative FLR assessment. PVE, associating liver partition and portal vein ligation, radiation lobectomy, and liver venous deprivation are all currently available techniques to hypertrophy the FLR. Each strategy has pros and cons based on tumor type, extent of resection, presence or absence of underlying liver disease, age, performance status, complication rates, and other factors. Summary Numerous strategies can lead to FLR hypertrophy and improve the safety of major hepatectomy. Which is best has yet to be determined.

[1]  M. Abecassis,et al.  Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma. , 2018, Journal of vascular and interventional radiology : JVIR.

[2]  Yasuhiko Nagano,et al.  Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. , 2006, Surgery.

[3]  C. Lambert,et al.  Combined Preoperative Portal and Hepatic Vein Embolization (Biembolization) to Improve Liver Regeneration Before Major Liver Resection: A Preliminary Report , 2017, World Journal of Surgery.

[4]  T. Baumert,et al.  Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature. , 2016, Minerva chirurgica.

[5]  D. Häussinger,et al.  Infusion of CD133+ Bone Marrow–Derived Stem Cells After Selective Portal Vein Embolization Enhances Functional Hepatic Reserves After Extended Right Hepatectomy: A Retrospective Single-Center Study , 2012, Annals of surgery.

[6]  N. Demartines,et al.  Preoperative Portal Vein Embolization Alone with Biliary Drainage Compared to a Combination of Simultaneous Portal Vein, Right Hepatic Vein Embolization and Biliary Drainage in Klatskin Tumor , 2018, CardioVascular and Interventional Radiology.

[7]  M. Nagino,et al.  Portal Vein Embolization before Extended Hepatectomy for Biliary Cancer: Current Technique and Review of 494 Consecutive Embolizations , 2012, Digestive Surgery.

[8]  W. Bechstein,et al.  Systematic Review and Meta-Analysis of Feasibility, Safety, and Efficacy of a Novel Procedure: Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy , 2015, Annals of Surgical Oncology.

[9]  A. Ruzzenente,et al.  How Much Remnant Is Enough in Liver Resection? , 2012, Digestive Surgery.

[10]  B. Isaksson,et al.  ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis , 2017, Annals of surgery.

[11]  M. Nagino,et al.  Immediate increase in arterial blood flow in embolized hepatic segments after portal vein embolization: CT demonstration. , 1998, AJR. American journal of roentgenology.

[12]  D. Gouma,et al.  Tumor Progression After Preoperative Portal Vein Embolization , 2012, Annals of surgery.

[13]  J. Shindoh,et al.  Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. , 2013, Journal of the American College of Surgeons.

[14]  A. Darzi,et al.  Rapid Induction of Liver Regeneration for Major Hepatectomy (REBIRTH): A Randomized Controlled Trial of Portal Vein Embolisation versus ALPPS Assisted with Radiofrequency , 2019, Cancers.

[15]  M. Besselink,et al.  99mTc-mebrofenin hepatobiliary scintigraphy predicts liver failure following major liver resection for perihilar cholangiocarcinoma. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[16]  S. Balzan,et al.  Outflow modulation to target liver regeneration: something old, something new. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  Olivier Ernst,et al.  Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. , 2007, Journal of the American College of Surgeons.

[18]  H. Bismuth,et al.  Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. , 2000, Annals of surgery.

[19]  B. Gayet,et al.  ALPPS as a salvage procedure after insufficient future liver remnant hypertrophy following portal vein occlusion. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[20]  D. Verzilli,et al.  Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function , 2017, European Radiology.

[21]  B. Trotovšek,et al.  Intrahepatic venous anastomoses with a focus on the middle hepatic vein anastomoses in normal human livers: anatomical study on liver corrosion casts , 2014, Surgical and Radiologic Anatomy.

[22]  E. Abdalla,et al.  Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. , 2005, Journal of vascular and interventional radiology : JVIR.

[23]  T. Baère,et al.  Predictive Factors for Hypertrophy of the Future Remnant Liver After Selective Portal Vein Embolization , 2010, Annals of Surgical Oncology.

[24]  M. Nagino,et al.  Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer , 2010, The British journal of surgery.

[25]  Y. Fong,et al.  Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections , 2009, World journal of surgical oncology.

[26]  Yongmin Chang,et al.  Quantitative Evaluation of Liver Function with MRI Using Gd-EOB-DTPA , 2004, Korean journal of radiology.

[27]  M. Reiser,et al.  Fibrosis, Portal Hypertension, and Hepatic Volume Changes Induced by Intra-arterial Radiotherapy with 90Yttrium Microspheres , 2008, Digestive Diseases and Sciences.

[28]  M. Mulcahy,et al.  Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. , 2009, Journal of vascular and interventional radiology : JVIR.

[29]  Steven A Curley,et al.  Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. , 2002, Archives of surgery.

[30]  N. Habib,et al.  Radio-frequency-assisted Liver Partition with Portal vein ligation (RALPP) for liver regeneration. , 2015, Annals of surgery.

[31]  D. Raptis,et al.  Early Survival and Safety of ALPPS: First Report of the International ALPPS Registry , 2014, Annals of surgery.

[32]  B. Isaksson,et al.  Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy , 2016, Journal of Gastrointestinal Surgery.

[33]  P. Parrilla,et al.  Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure , 2014, The British journal of surgery.

[34]  W. Jarnagin,et al.  Hepatic parenchymal transection increases liver volume but not function after portal vein embolization in rabbits , 2017 .

[35]  Franck Vandenbroucke-Menu,et al.  Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[36]  E. Abdalla,et al.  Accuracy of estimated total liver volume formulas before liver resection. , 2019, Surgery.

[37]  D. Nagorney,et al.  Trends in Morbidity and Mortality of Hepatic Resection for Malignancy A Matched Comparative Analysis , 1994, Annals of surgery.

[38]  I. Renfrew,et al.  Portal Vein Embolization Using a Nitinol Plug (Amplatzer Vascular Plug) in Combination with Histoacryl Glue and Iodinized Oil: Adequate Hypertrophy with a Reduced Risk of Nontarget Embolization , 2009, CardioVascular and Interventional Radiology.

[39]  K. Sung,et al.  Interventional oncology: new options for interstitial treatments and intravascular approaches , 2010, Journal of hepato-biliary-pancreatic sciences.

[40]  Ming Zhang,et al.  The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients. , 2014, The Journal of surgical research.

[41]  C. Tschuor,et al.  ALPPS Offers a Better Chance of Complete Resection in Patients with Primarily Unresectable Liver Tumors Compared with Conventional-Staged Hepatectomies: Results of a Multicenter Analysis , 2014, World Journal of Surgery.

[42]  U. Neumann,et al.  Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity , 2017, Annals of surgery.

[43]  V. Ardiles,et al.  Inverting the ALPPS paradigm by minimizing first stage impact: the Mini-ALPPS technique , 2016, Langenbeck's Archives of Surgery.

[44]  M. Nishizawa,et al.  Stimulation of liver regeneration after hepatectomy in mice by injection of bone marrow mesenchymal stem cells via the portal vein. , 2012, Transplantation proceedings.

[45]  J. Ertle,et al.  Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma. , 2014, Clinical radiology.

[46]  M. Makuuchi,et al.  Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. , 1990, Surgery.

[47]  M. Nagino,et al.  Portal and arterial embolization before extensive liver resection in patients with markedly poor functional reserve. , 2000, Journal of vascular and interventional radiology : JVIR.

[48]  J. Belghiti,et al.  ALPPS: Innovation for innovation's sake. , 2016, Surgery.

[49]  O. V. van Delden,et al.  Portal Vein Embolization Before Liver Resection: A Systematic Review , 2012, CardioVascular and Interventional Radiology.

[50]  M. Nagino,et al.  Two Hundred Forty Consecutive Portal Vein Embolizations Before Extended Hepatectomy for Biliary Cancer: Surgical Outcome and Long-term Follow-Up , 2006, Annals of surgery.

[51]  T. Utsunomiya,et al.  Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. , 1999, Journal of the American College of Surgeons.

[52]  H. Schlitt,et al.  Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings , 2012, Annals of surgery.

[53]  M. Besselink,et al.  Functional and volumetric assessment of liver segments after portal vein embolization: Differences in hypertrophy response , 2019, Surgery.

[54]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[55]  T. de Baère,et al.  Portal vein embolization: a plea for strict patient selection. , 2006, AJR. American journal of roentgenology.

[56]  M. Nagino,et al.  Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. , 1996, Radiology.

[57]  M. Nagino,et al.  Mechanisms of Hepatic Regeneration Following Portal Vein Embolization and Partial Hepatectomy: A Review , 2007, World Journal of Surgery.

[58]  G. Torzilli,et al.  "Precision Surgery" for Colorectal Liver Metastases: Is the Time Ripe? , 2018, Annals of surgery.

[59]  K. Oldhafer,et al.  Avoiding postoperative mortality after ALPPS-development of a tumor-specific risk score for colorectal liver metastases. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[60]  P. Bie,et al.  Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats. , 2013, The Journal of surgical research.

[61]  J. D'haese,et al.  Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC? , 2015, Annals of Surgical Oncology.

[62]  T. V. van Gulik,et al.  99mTc-Mebrofenin Hepatobiliary Scintigraphy with SPECT for the Assessment of Hepatic Function and Liver Functional Volume Before Partial Hepatectomy , 2010, Journal of Nuclear Medicine.

[63]  T. Muto,et al.  Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization , 2001, Hepatology.

[64]  T. de Baère,et al.  During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma , 1999, The British journal of surgery.

[65]  I. Endo,et al.  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[66]  J. Vauthey,et al.  Indications for and limitations of portal vein embolization before major hepatic resection for hepatobiliary malignancy. , 2002, Surgical oncology clinics of North America.

[67]  P. Bachellier,et al.  A Two-Stage Hepatectomy Procedure Combined With Portal Vein Embolization to Achieve Curative Resection for Initially Unresectable Multiple and Bilobar Colorectal Liver Metastases , 2004, Annals of surgery.

[68]  B. Isaksson,et al.  ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM , 2019, Annals of surgery.

[69]  H. Richardson,et al.  Practical guidelines for the use of technetium-99m mebrofenin hepatobiliary scintigraphy in the quantitative assessment of liver function , 2019, Nuclear medicine communications.

[70]  N. Bucher,et al.  THE RATE OF INCORPORATION OF LABELED THYMIDINE INTO THE DEOXYRIBONUCLEIC ACID OF REGENERATING RAT LIVER IN RELATION TO THE AMOUNT OF LIVER EXCISED. , 1964, Cancer research.

[71]  J. Kim,et al.  Liver Regeneration and the Atrophy-Hypertrophy Complex , 2008, Seminars in interventional radiology.

[72]  R. Salem,et al.  Neoadjuvant Radiation Lobectomy As an Alternative to Portal Vein Embolization in Hepatocellular Carcinoma. , 2019, Seminars in nuclear medicine.

[73]  W. Jarnagin,et al.  High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[74]  G. Poston,et al.  Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[75]  A. Schnitzbauer,et al.  The HPB controversy of the decade: 2007-2017 - Ten years of ALPPS. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[76]  A. Bergquist,et al.  Dynamic gadoxetate‐enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis , 2014, Journal of magnetic resonance imaging : JMRI.

[77]  S. Curley,et al.  Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. , 2009, Surgery.

[78]  P. Rouanet,et al.  Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique , 2016, European Radiology.

[79]  S. Francque,et al.  Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure? , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[80]  J. Shindoh,et al.  Safety and Efficacy of Portal Vein Embolization Before Planned Major or Extended Hepatectomy: An Institutional Experience of 358 Patients , 2013, Journal of Gastrointestinal Surgery.

[81]  M. Makuuchi,et al.  Effects of middle hepatic vein reconstruction on right liver graft regeneration , 2003, Transplantation.

[82]  D. Seehofer,et al.  Preliminary study on liver function changes after trisectionectomy with versus without prior portal vein embolization , 2016, Surgery Today.

[83]  J. Belghiti,et al.  Which limits to the "ALPPS" approach? , 2012, Annals of surgery.

[84]  E. Abdalla,et al.  Prediction of Mortality After ALPPS Stage-1: An Analysis of 320 Patients From the International ALPPS Registry. , 2015, Annals of surgery.

[85]  C. Tschuor,et al.  Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[86]  L. V. van Vliet,et al.  Comparison between dynamic gadoxetate-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function , 2019, European Radiology.

[87]  T. de Baère,et al.  Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. , 2008, Seminars in interventional radiology.

[88]  K. Yamazaki,et al.  Immaturity of Bile Canalicular–Ductule Networks in the Future Liver Remnant While Associating Liver Partition and Portal Vein Occlusion for Staged Hepatectomy (ALPPS) , 2017, Annals of Surgical Oncology.

[89]  J. Vauthey,et al.  Re "Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections". , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[90]  H. Bismuth,et al.  Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors , 2000, Annals of surgery.

[91]  Danby Kang,et al.  Hypertrophy and Liver Function in ALPPS: Correlation with Morbidity and Mortality , 2017, Visceral Medicine.

[92]  S. Francque,et al.  Future remnant liver function estimated by combining liver volumetry on MRI with total liver function on 99mtc-mebrofenin hepatobiliary scintigraphy : Can this tool predict post-hepatectomy liver failure? , 2016 .

[93]  V. Ardiles,et al.  Interstage Assessment of Remnant Liver Function in ALPPS Using Hepatobiliary Scintigraphy: Prediction of Posthepatectomy Liver Failure and Introduction of the HIBA Index , 2018, Annals of surgery.

[94]  T. V. van Gulik,et al.  Increase in future remnant liver function after preoperative portal vein embolization , 2011, The British journal of surgery.

[95]  M. Choti,et al.  Preoperative Chemotherapy for Colorectal Liver Metastases: Impact on Hepatic Histology and Postoperative Outcome , 2007, Journal of Gastrointestinal Surgery.

[96]  K. Ahrar,et al.  Transhepatic portal vein embolization: anatomy, indications, and technical considerations. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

[97]  W. Jarnagin,et al.  Acknowledging the flaws to advance with the strengths of ALPPS. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[98]  S. Truant,et al.  Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function , 2017, Surgery.

[99]  E. Achilles,et al.  Avoid "All-Touch" by Hybrid ALPPS to Achieve Oncological Efficacy. , 2016, Annals of surgery.

[100]  M. Abecassis,et al.  90Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes , 2016, Journal of surgical oncology.

[101]  V. Ardiles,et al.  Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS): Tips and Tricks , 2013, Journal of Gastrointestinal Surgery.

[102]  T. V. van Gulik,et al.  Current Modalities for the Assessment of Future Remnant Liver Function , 2017, Visceral Medicine.

[103]  M. Lesurtel,et al.  Is partial-ALPPS safer than ALPPS? A single-center experience. , 2015, Annals of surgery.

[104]  M. Nagino,et al.  Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. , 1995, Surgery.

[105]  J. Vauthey,et al.  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? , 2012, Annals of surgery.

[106]  E. Abdalla,et al.  Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome , 2007, The British journal of surgery.

[107]  H. Kinoshita,et al.  Preoperative portal vein embolization for hepatocellular carcinoma , 1986, World Journal of Surgery.

[108]  N. Habib,et al.  Preoperative Portal Vein Embolization for Major Liver Resection: A Meta-Analysis , 2008, Annals of surgery.

[109]  B. Guiu,et al.  Extended Liver Venous Deprivation Leads to a Higher Increase in Liver Function that ALPPS in Early Assessment , 2017, Journal of Gastrointestinal Surgery.

[110]  Thomas G. Walker,et al.  Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions. , 2017, Journal of vascular and interventional radiology : JVIR.

[111]  D. Gouma,et al.  Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[112]  A. Kaseb,et al.  Anti-angiogenic therapy in the setting of TACE: an elusive synergy? , 2018, The lancet. Gastroenterology & hepatology.

[113]  Amin Rostami-Hodjegan,et al.  Changes in liver volume from birth to adulthood: A meta‐analysis , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[114]  M. Aljiffry,et al.  Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[115]  U. Neumann,et al.  The ALPPS Risk Score: Avoiding Futile Use of ALPPS , 2016, Annals of surgery.

[116]  M. Besselink,et al.  Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization , 2017, Surgery.

[117]  M. Abecassis,et al.  Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. , 2013, Journal of hepatology.

[118]  M. Abecassis,et al.  Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization , 2009, Annals of Surgical Oncology.

[119]  K. Sung,et al.  Sequential Preoperative Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization to Induce Further Liver Regeneration in Patients With Hepatobiliary Malignancy , 2009, Annals of surgery.

[120]  K. Boudjema,et al.  Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[121]  C. Punt,et al.  Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case‐matched comparison with palliative systemic therapy , 2017, Surgery.

[122]  Jaap Stoker,et al.  New Perspectives in the Assessment of Future Remnant Liver , 2014, Digestive Surgery.

[123]  S. Cai,et al.  Sonographic classification of draining pathways of obstructed hepatic veins in Budd‐Chiari syndrome , 2014, Journal of clinical ultrasound : JCU.

[124]  H. Eguchi,et al.  Real-Time Intraoperative Assessment of Residual Liver Functional Reserve Using Pulse Dye Densitometry , 2008, World Journal of Surgery.

[125]  Y. Kodama,et al.  Complications of percutaneous transhepatic portal vein embolization. , 2002, Journal of vascular and interventional radiology : JVIR.

[126]  G. Stavrou,et al.  How much liver needs to be transected in ALPPS? A translational study investigating the concept of less invasiveness , 2017, Surgery.

[127]  O. Sgarbura,et al.  Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center. , 2019, Hepatobiliary surgery and nutrition.

[128]  P. Bachellier,et al.  Two‐stage hepatectomy for multiple bilobar colorectal liver metastases , 2011, The British journal of surgery.

[129]  Lawrence H. Schwartz,et al.  Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection , 2003, Journal of Gastrointestinal Surgery.

[130]  T. de Baère,et al.  Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. , 2005, Radiology.

[131]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[132]  Erhard Godehardt,et al.  Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. , 2007, Radiology.